Hepatic steatosis and fibrosis: Non-invasive assessment.
Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation and cons...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Baidisheng Publishing Group
2016
|
| _version_ | 1826261812727775232 |
|---|---|
| author | Karanjia, RN Crossey, MME Cox, IJ Fye, HKS Njie, R Goldin, RD Taylor-Robinson, SD |
| author_facet | Karanjia, RN Crossey, MME Cox, IJ Fye, HKS Njie, R Goldin, RD Taylor-Robinson, SD |
| author_sort | Karanjia, RN |
| collection | OXFORD |
| description | Chronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation and consequent fibrosis, although hepatic steatosis is increasingly being recognised as an important pathological feature of disease, rather than being simply an innocent bystander. However, the current gold standard method of quantifying and staging liver disease, histological analysis by liver biopsy, has several limitations and can have associated morbidity and even mortality. Therefore, there is a clear need for safe and non-invasive assessment modalities to determine hepatic steatosis, inflammation and fibrosis. This review covers key mechanisms and the importance of fibrosis and steatosis in the progression of liver disease. We address non-invasive imaging and blood biomarker assessments that can be used as an alternative to information gained on liver biopsy. |
| first_indexed | 2024-03-06T19:26:28Z |
| format | Journal article |
| id | oxford-uuid:1be2ac05-4663-49b7-b4dd-5462e5f5c820 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:26:28Z |
| publishDate | 2016 |
| publisher | Baidisheng Publishing Group |
| record_format | dspace |
| spelling | oxford-uuid:1be2ac05-4663-49b7-b4dd-5462e5f5c8202022-03-26T11:02:52ZHepatic steatosis and fibrosis: Non-invasive assessment.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:1be2ac05-4663-49b7-b4dd-5462e5f5c820EnglishSymplectic Elements at OxfordBaidisheng Publishing Group2016Karanjia, RNCrossey, MMECox, IJFye, HKSNjie, RGoldin, RDTaylor-Robinson, SDChronic liver disease is a major cause of morbidity and mortality worldwide and usually develops over many years, as a result of chronic inflammation and scarring, resulting in end-stage liver disease and its complications. The progression of disease is characterised by ongoing inflammation and consequent fibrosis, although hepatic steatosis is increasingly being recognised as an important pathological feature of disease, rather than being simply an innocent bystander. However, the current gold standard method of quantifying and staging liver disease, histological analysis by liver biopsy, has several limitations and can have associated morbidity and even mortality. Therefore, there is a clear need for safe and non-invasive assessment modalities to determine hepatic steatosis, inflammation and fibrosis. This review covers key mechanisms and the importance of fibrosis and steatosis in the progression of liver disease. We address non-invasive imaging and blood biomarker assessments that can be used as an alternative to information gained on liver biopsy. |
| spellingShingle | Karanjia, RN Crossey, MME Cox, IJ Fye, HKS Njie, R Goldin, RD Taylor-Robinson, SD Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title | Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title_full | Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title_fullStr | Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title_full_unstemmed | Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title_short | Hepatic steatosis and fibrosis: Non-invasive assessment. |
| title_sort | hepatic steatosis and fibrosis non invasive assessment |
| work_keys_str_mv | AT karanjiarn hepaticsteatosisandfibrosisnoninvasiveassessment AT crosseymme hepaticsteatosisandfibrosisnoninvasiveassessment AT coxij hepaticsteatosisandfibrosisnoninvasiveassessment AT fyehks hepaticsteatosisandfibrosisnoninvasiveassessment AT njier hepaticsteatosisandfibrosisnoninvasiveassessment AT goldinrd hepaticsteatosisandfibrosisnoninvasiveassessment AT taylorrobinsonsd hepaticsteatosisandfibrosisnoninvasiveassessment |